10-Q - Global Innovative Platforms Inc. (0001837774) (Filer)

Thu, May 15, 8:37 PM (36 days ago)

**Global Innovative Platforms, Inc. (Ticker: Not Provided)** **Q1 2025 Financial Health and Performance:** Global Innovative Platforms, Inc. reported no revenue for Q1 2025, indicating no revenue-generating activities. The company incurred significant general and administrative expenses totaling $151,351, leading to an operating loss of $151,351 for the quarter. This is a substantial increase compared to the $3,887 operating loss in Q1 2024. The primary expenses included venture capital consulting, license fees, research costs, facilities rental, professional fees, and other administrative costs. **Financial Metrics:** - **Revenue:** $0 (Q1 2025), $0 (Q1 2024) - **Operating Loss:** $151,351 (Q1 2025), $3,887 (Q1 2024) - **Net Loss:** $151,351 (Q1 2025), $3,887 (Q1 2024) - **Cash Flow from Operating Activities:** -$311,606 (Q1 2025), $27,225 (Q1 2024) - **Cash Flow from Financing Activities:** $467,500 (Q1 2025), $27,386 (Q1 2024) **Profit Margins:** Not applicable due to zero revenue. **Cash Flow and Earnings Changes:** The company experienced a significant negative cash flow from operating activities, primarily due to increased expenses. However, financing activities provided a positive cash inflow of $467,500, mainly from the sale of common stock. **Quarterly Performance Discussion:** Global Innovative Platforms, Inc. is in the development stage, focusing on advancing animal health through breath analysis and air quality technology. The company's proprietary technologies, "VOCAM Plus" and the "FROG," utilize advanced gas chromatography and A.I. software for breath and air analysis. Despite the lack of revenue, the company is investing in research and development to advance its diagnostic tools. **Trends and Uncertainties:** The company faces substantial uncertainties regarding its ability to continue as a going concern. It relies heavily on raising additional equity and/or debt to meet ongoing operating expenses. There is no assurance that the company will be able to secure the necessary funding or achieve profitability in the near future. **Future Operations Impact:** The company's future operations will depend on its ability to secure funding, develop its technologies, and eventually generate revenue. The success of its diagnostic tools and the market demand for its products will be critical factors in its future performance.